Kestra Advisory Services’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
11,775
+728
| +7% | +$26.2K | ﹤0.01% | 2078 |
|
|
2025
Q1 | $436K | Sell |
11,047
-1,896
| -15% | -$74.8K | ﹤0.01% | 1906 |
|
|
2024
Q4 | $390K | Buy |
12,943
+200
| +2% | +$6.02K | ﹤0.01% | 2035 |
|
|
2024
Q3 | $298K | Sell |
12,743
-615
| -5% | -$14.4K | ﹤0.01% | 2086 |
|
|
2024
Q2 | $238K | Sell |
13,358
-9,866
| -42% | -$176K | ﹤0.01% | 2278 |
|
|
2024
Q1 | $353K | Sell |
23,224
-537
| -2% | -$8.17K | ﹤0.01% | 1889 |
|
|
2023
Q4 | $406K | Buy |
23,761
+7,419
| +45% | +$127K | ﹤0.01% | 1649 |
|
|
2023
Q3 | $137K | Buy |
16,342
+1,240
| +8% | +$10.4K | ﹤0.01% | 1987 |
|
|
2023
Q2 | $375K | Sell |
15,102
-4,756
| -24% | -$118K | ﹤0.01% | 1475 |
|
|
2023
Q1 | $299K | Buy |
+19,858
| New | +$299K | ﹤0.01% | 1563 |
|